| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.8M | -15.6% |
| Cost of Revenue | $14.5M | -2.1% |
| Gross Profit | -$3.7M | -82.8% |
| R&D Expense | $7.1M | +11.2% |
| SG&A Expense | $13.3M | +5.4% |
| Operating Income | -$29.7M | -12.9% |
| Pre-tax Income | -$31.7M | -43.5% |
| Income Tax | $0 | — |
| Net Income | -$31.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.1M | +387.5% |
| Accounts Receivable | $1.7M | -17.2% |
| Inventory | $1.8M | -22.5% |
| Current Assets | $15.1M | +83.8% |
| Total Assets | $28.2M | +22.7% |
| Current Liabilities | $8.3M | +19.0% |
| Long-term Debt | $4.0M | +218.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.5M | +7.0% |
| Capital Expenditures | $43K | -90.6% |
| Investing Cash Flow | -$3.2M | +38.0% |
| Financing Cash Flow | $34.5M | +28.4% |
| Free Cash Flow | -$22.5M | +8.6% |
| -43.5% |
| EPS (Basic) | -$10.97 | -3126.5% |
| EPS (Diluted) | -$10.97 | -3126.5% |
| Total Liabilities |
| $12.4M |
| -19.5% |
| Stockholders' Equity | $15.8M | +159.3% |